High-dose monoclonal antibodies via the subcutaneous route: challenges and technical solutions, an industry perspective.
This review summarizes the various challenges in product development involved in subcutaneous administration of high-dose monoclonal antibodies and attempts to provide an industry perspective of some of the available technologies and potential avenues to overcome these challenges.